XML 35 R24.htm IDEA: XBRL DOCUMENT v3.23.3
Description Of Business Segments (Tables)
9 Months Ended
Sep. 30, 2023
Revenue from External Customer  
Information Concerning Consolidated Operations by Business Segment
Information concerning consolidated operations by business segment is presented in the following tables:
Three Months Ended September 30Nine Months Ended September 30
20232022Change20232022Change
NET SALES
Personal Care$2,700 $2,628 +3 %$8,089 $8,067 — 
Consumer Tissue1,567 1,578 -1 %4,750 4,683 +1 %
K-C Professional854 836 +2 %2,588 2,418 +7 %
Corporate & Other11 11 N.M.34 43 N.M.
TOTAL NET SALES$5,132 $5,053 +2 %$15,461 $15,211 +2 %
OPERATING PROFIT
Personal Care$502 $423 +19 %$1,461 $1,364 +7 %
Consumer Tissue267 218 +22 %707 567 +25 %
K-C Professional168 119 +41 %514 294 +75 %
Corporate & Other(a)
(128)(90)N.M.(1,013)(298)N.M.
Other (income) and expense, net(a)
35 15 +133 %(5)(42)-88 %
TOTAL OPERATING PROFIT$774 $655 +18 %$1,674 $1,969 -15 %
(a)    Corporate & Other and Other (income) and expense, net include income and expense not associated with the business segments, including in 2023 the net benefit related to the sale of our Brazil tissue and K-C Professional business and the impairment of intangible assets, and in 2022 the non-cash, non-recurring gain and transaction and integration costs related to the acquisition of a controlling interest in Thinx.
N.M. - Not Meaningful
[1]
Sales of Principal Products
Sales of Principal Products:
Three Months Ended September 30Nine Months Ended September 30
(Billions of dollars)2023202220232022
Baby and child care products$1.8 $1.7 $5.3 $5.5 
Consumer tissue products1.6 1.6 4.8 4.7 
Away-from-home professional products0.9 0.8 2.6 2.4 
All other0.8 1.0 2.8 2.6 
Consolidated$5.1 $5.1 $15.5 $15.2 
[1] Corporate & Other and Other (income) and expense, net include income and expense not associated with the business segments, including in 2023 the net benefit related to the sale of our Brazil tissue and K-C Professional business and the impairment of intangible assets, and in 2022 the non-cash, non-recurring gain and transaction and integration costs related to the acquisition of a controlling interest in Thinx.N.M. - Not Meaningful